Secondly, although EGFR-TKI monotherapy could reduce AEs, considering tumor heterogeneity and the efficacy of other treatment regimens, including chemotherapy and radiotherapy, different combination therapies should also be further investigated for assessing the optimal adjuvant therapy (22). Here, EGFR is linked to neoplasm.